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The merozoite surface antigen 2 (MSA-2) proteins of Babesia bovis are members of the variable merozoite
surface antigen (VMSA) family that have been implicated in erythrocyte invasion and are important targets for
antibody-mediated blocking of invasion. Extensive sequence variation in another VMSA member, MSA-1, has
been shown in all vaccine breakthrough isolates. To test the hypothesis that the msa-2 genes of vaccine
breakthrough isolates would also encode a diverse set of proteins, the complete msa-2 locus was characterized
from 12 Australian B. bovis strains and isolates, including two vaccine strains and eight vaccine breakthrough
isolates, and compared to the loci in previously and newly characterized American strains. In contrast to
American strains, the msa-2 loci of all Australian strains and isolates examined contain, in addition to msa-2c,
only a solitary gene (designated msa-2a/b) closely related to American strain msa-2a and msa-2b. Nevertheless,
the proteins encoded by these genes are quite diverse both between and within geographic regions and harbor
evidence of genetic exchange among other VMSA family members, including msa-1. Moreover, all but one of
the Australian breakthrough isolate MSA-2a/b proteins is markedly different from the vaccine strain from
which immune escape occurred, consistent with their role in strain-specific protective immunity. The densest
distribution of polymorphisms occurs in a hypervariable region (HVR) within the carboxy third of the molecule
that is highly proline rich. Variation in length and content of the HVR is primarily attributable to differences
in the order and number of degenerate nucleotide repeats encoding three motifs of unknown function.
Proteins found on the cell surface of apicomplexan hemo-
parasitic merozoites, such as Babesia and Plasmodium species,
are important for erythrocyte invasion and, consequently, host
immunity. How these proteins function and the mechanisms
utilized to avoid immune recognition are critical to developing
strategies for vaccination. The variable merozoite surface an-
tigen (VMSA) family of Babesia bovis, an important cause of
bovine babesiosis, encodes immunodominant, glycosylphos-
phatidylinositol (GPI)-anchored, membrane surface proteins
coexpressed in both merozoites and sporozoites (16, 17). The
family is defined by conserved amino- and carboxy-terminal
regions, encoding leader and anchor signals, respectively, and
a characteristic central hydrophilic structure (6, 10, 26). Mem-
bers of the family include merozoite surface antigen 1 (MSA-
1), MSA-2, and the distantly related BabR (6). Unlike msa-1,
which is present as a single-copy gene (26), the msa-2 locus of the
biological clone Mo7 is organized into four tandemly arranged
and expressed genes (two msa-2a genes, msa-2b, and msa-2c)
(10). Because the proteins encoded by the two msa-2a genes and
msa-2b have a high degree of identity to each other (78 to 90%)
with distinctly conserved regions, a shared function is postulated.
The potential role that the MSA-2a and -2b proteins have in
erythrocyte invasion is illustrated by the ability of MSA-2a and
-2b monospecific antisera to significantly inhibit sporozoite and
merozoite invasion of erythrocytes (16), consistent with their
coexpression on the merozoite surface.
Although attenuated vaccines generally provide protection
against bovine babesiosis, disease outbreaks involving heterol-
ogous isolates occur (4, 5). These heterologous field isolates,
termed vaccine breakthrough isolates, are genetically distinct
from the vaccine strain used to immunize animals (13). How-
ever, the composite genetic and antigenic changes that result in
vaccine breakthrough are not defined. LeRoith et al. recently
showed that significant MSA-1 variation was present in every
vaccine breakthrough isolate examined (12). Based on studies
using American strains (defined by geographic origins), MSA-2
has been postulated to be less divergent despite apparent in-
tragenic sites of genetic exchange (10). However, because of
their familial relationship, we hypothesized that MSA-2 would
demonstrate similar sequence divergence when examined in
isolates of B. bovis able to escape vaccine-induced immunity.
Further, this divergence was postulated to arise in part from
genetic exchange among VMSA family members. To test these
hypotheses, we characterized the complete msa-2 locus from
12 Australian strains and isolates, including two vaccine strains
and eight vaccine breakthrough isolates, and compared the
msa-2 genes to the two previously characterized loci (10) as
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well as one new American isolate. The results identify a unique
structure of the msa-2 locus in Australian strains and isolates
and confirm the hypothesis that significant sequence variation
occurs in breakthrough isolates. While genetic exchange does
appear to contribute to sequence diversity, unique degenerate
nucleotide repeats encode much of the variation in a proline-
rich hypervariable region (HVR) occupying the carboxy third
of MSA-2a/MSA-2b proteins.
MATERIALS AND METHODS
Parasites and DNA. The origins of all strains and isolates used, along with
relevant references, are shown in Table 1. Strains are defined as well-character-
ized, passaged or cultured stocks of B. bovis and include the T and K vaccine
strains and the T2Bo, L, and S strains. Isolates are those parasite stocks isolated
during Australian B. bovis outbreaks. The biological clone Mo7, the T2Bo strain,
and the L strain were maintained in microaerophilic stationary-phase blood cell
cultures as described elsewhere (8). Genomic DNA was isolated by sodium
dodecyl sulfate lysis-proteinase K digestion, followed by phenol-chloroform ex-
tractions and a standard ethanol precipitation (24); for the Australian S strain,
DNA was isolated from stabilates by guanidine hydrochloride extraction utilized
in the QIAamp DNA Blood Midi kit (QIAGEN, Valencia, CA).
Probe synthesis and Southern blotting. T2Bo strain and L strain msa-2a/
b-specific, amino-modified, digoxigenin-labeled, oligonucleotide probes (Inte-
grated DNA Technologies, Coralville, IA) were designed from the leader
sequence of msa-2b and msa-2a/b sequences, respectively (sequences are shown
in Table 2). For blotting experiments, approximately 2 micrograms of genomic
DNA was digested overnight with HindIII/EcoRI (L strain) or PstI (T2Bo
strain); HindIII/EcoRI cuts just outside the L msa-2a/b gene, and PstI cuts
upstream of msa-2a1 (the most 5 msa-2a/b gene) and 176 bp from the 3 end of
msa-2b (the most 3 msa-2a/b gene) in T2Bo. Digested DNA was electropho-
resed on an 0.8% agarose gel and blotted overnight to positively charged nylon
membranes (Roche Applied Science, Indianapolis, IN). The membranes were
hybridized in DIG Easy Hyb (Roche Applied Science) with digoxigenin-labeled
probes overnight at 42°C. The membranes were washed in 0.5% SSC (1 SSC is
0.15 M NaCl plus 0.015 M sodium citrate) and 0.1% sodium dodecyl sulfate at
42°C for 30 min. Chemiluminescence detection of the probe was carried out as
directed (Roche Applied Science).
Amplification and sequencing of msa-2 loci from B. bovis isolates and strains.
The msa-2 locus (extending from the start codon of msa-2c to orfB) of S, L, T,
and T2Bo strains and the G series, F3, F35, and F40 isolates was amplified from
genomic DNA employing temperature gradient PCR. The locus of T2Bo, S, L,
T, F35, G36, and G51 was amplified with primer set msa-2c-F and orf-b-F, and
the locus of G06, G52, F3, and F40 was amplified with primer set msa-2c-F and
orf-b-F3. The final concentrations in reaction mixtures were 200 M de-
oxynucleoside triphosphates, 2 mM MgSO4, 500 nM primers, 2% dimethyl sul-
foxide, and 1 U Platinum Taq DNA High Fidelity polymerase (Invitrogen).
Cycling, following a 5-min 95°C hot start, was carried out as follows: denaturation
for 30 s at 95°C, annealing for 30 s ranging from 50°C to 60°C, and extension for
8 min at 68°C for 35 cycles, concluding with a 10-min extension at 72°C. Appro-
priately sized amplicons were cloned into pCR-4-TOPO. The T2Bo msa-2 am-
TABLE 1. Strains and isolates used in msa-2 locus and gene analyses
Strain Isolation yr Origin Comment Reference(s)
American strains
Mo7 1983 Mexico Biological clone obtained by limiting dilution
of a field isolate
23
R1A 1990 Argentina Vaccine strain attenuated by rapid passage in
splenectomized calves
2
T2Bo 1978 South Texas Virulent strain passaged 2 through
splenectomized calves
19
Australian strains/isolates
L 1965 New South Wales Virulent strain isolated from field-infected
ticks passaged 2 in splenectomized calves
15
S 1969 Queensland Virulent field strain passaged 3 in
splenectomized calves
15
K 1975 Queensland Vaccine strain attenuated by rapid passage in
splenectomized calves
4, 5
T 1987 Queensland Vaccine strain attenuated by rapid passage in
splenectomized calves
4, 5
F3, F28, F35, F40 1989–1990 Queensland Breakthrough field isolates from cattle
vaccinated with K vaccine strain
13
G06, G36, G51, G52 1991–1993 Queensland Breakthrough field isolates from cattle
vaccinated with T vaccine strain
13
TABLE 2. Oligonucleotides used for the amplification of msa-2 loci and msa-2 genes and Southern blot experiments
Primer Application(s) Sequence (5–3)
msa-2c-F Locus PCR, PCR ATGGTGTCTTTTAACATAATAAC
B42/44-R PCR AAAATGCAGAGAGAACG
B42/44-R-f PCR CTCTCTGCTACTTCGTTCTCTCTGC
msa-2-F1 PCR ATGATCGGGAAAATCTTC
msa-2-F1-r PCR CTGTGATTCCTCAGAAGCAGACAC
msa-2-F1-k PCR ATGATCGGCAAAATCTTT
aus-IR-F PCR GTGTAGATTTCTACCATTGCATTCGC
orf-b-F Locus PCR, PCR TATGGCGGGTTATGGATAACTCC
orf-b-F3 Locus PCR CTACTGGCAAATGACGATTTCGTG
orf-b-R PCR CGGGCGGTATTTTATGTATTTCCG
L-msa2-p Southern blots ATGATCGGCAAAATCTTC
T2Bo-msa2-p Southern blots ATGATCGGGAAAATCTTC
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plicon, after agarose gel isolation, was cloned into pCR-XL-TOPO (Invitrogen,
Carlsbad, CA). Positive clones were analyzed by PCR or restriction enzyme
digestion.
The cloned loci, except for T2Bo, were sequenced by subcloning four over-
lapping PCR amplicons that spanned the original insert. The msa-2c and -2a/b
genes were amplified from plasmids containing complete loci using the primer
sets described below and cloned into pCR-4-TOPO. The intergenic region be-
tween msa-2c and -2a/b and the intergenic region between msa-2a/b and orfB
were amplified from plasmid DNA using primer sets B42/44-R-f with msa-2-F1-r
and B42/44-R-f with orf-b-F3, respectively. Miniprep DNA was sequenced using
ABI chemistries and analyzed on an ABI3100 genetic analyzer (Applied Biosys-
tems, Foster City, CA). The four subclone sequences were compiled into a single
contiguous sequence using ContigExpress (Invitrogen). The T2Bo msa-2 locus
sequence was derived from shotgun sequencing of a BAC clone (1K11) gener-
ated from a genomic DNA library of the T2Bo strain (www.vetmed.wsu.edu
/research_vmp/babesia-bovis), followed by verification via subcloning and se-
quencing.
Amplification and sequencing of msa-2 genes from B. bovis isolates and
strains. msa-2a and -2b of the T2Bo strain and msa-2a/b of strains or isolates L,
S, F28, F35, T (T-1 msa-2a/b), and G06 were amplified from genomic DNA using
primer set msa-2-F1 and B42/44-R with Taq DNA polymerase (Invitrogen).
msa-2a/b of the K strain was amplified from genomic DNA using primer set
msa-2-F1-k and B42/44-R. msa-2c of the K, S, L, T, and T2Bo strains and the F
and G isolates was amplified with primer set msa-2c-F and B42/44-R. Additional
msa-2a/b genes were amplified from cloned msa-2 loci (see above). msa-2a/b of
isolates G36 and F35 was amplified from locus clones with primer set msa-2-F1
and B42/44-R. An msa-2a/b gene from the T strain (sequence T-2 msa-2a/b) and
msa-2a/b from isolates G06, G51, G52, F3, and F40 were amplified from locus
clones with primer set aus-IR-F and B42/44-R (primer sequences shown in
Table 2). Amplicons were cloned into pCR-4-TOPO (Invitrogen). Screening for
positive clones, end sequencing, and analyses were done as described above.
Nine additional T msa-2a/b clones—amplified with forward primer msa-1-F1,
aus-IR-F, or msa-1-F1-k and reverse primer B42/44—were sequenced and nearly
identical to either T-1 or T-2 msa-2a/b. Similarly, nine additional K msa-2a/b
clones—amplified with forward primer msa-1-F1-k or aus-IR-F and reverse
primer B42/44—were sequenced and nearly identical to K msa-2a/b.
The protein secondary structure of MSA-2a/b was analyzed by SSpro (www
.igb.uci.edu/tools/scratch/) and nnPredict (www.cmpharm.ucsf.edu/nomi/nnpredict
.html).
GenBank sequence accession numbers. GenBank accession numbers of the
previously published genomic DNA sequences from which protein sequences
were derived are as follows: Mo7 msa-2 locus, AY052538; R1A msa-2a1,
AY052539; R1A msa-2a2, AY052540; R1A msa-2b, AY052541; and R1A msa-
2c, AY052542.
Nucleotide sequence accession numbers. GenBank accession numbers of the
new genomic DNA sequences from which protein sequences were derived are as
follows: F28 msa-2a/b, DQ173946; F3 msa-2a/b, DQ173947; F35 msa-2a/b,
DQ173948; F40 msa-2a/b, DQ173949; G06 msa-2a/b, DQ173950; G36 msa-2a/b,
DQ173951; G51 msa-2a/b, DQ173952; G52 msa-2a/b, DQ173953; K vaccine
strain msa-2a/b, DQ173954; L strain msa-2a/b, DQ173955; S strain msa-2a/b,
DQ173956; T vaccine strain msa-2a/b T-1, DQ173957; T vaccine strain msa-2a/b
T-2, DQ173958; T2Bo strain msa-2a1, DQ173959; T2Bo strain msa-2a2,
DQ173960; T2Bo strain msa-2b, DQ173961; F28 msa-2c, DQ173962; F3 msa-2c,
DQ173963; F35 msa-2c, DQ173964; F40 msa-2c, DQ173965; G06 msa-2c,
DQ173966; G36 msa-2c, DQ173967; G51 msa-2c, DQ173968; G52 msa-2c,
DQ173969; K vaccine strain msa-2c, DQ173970; L strain msa-2c, DQ173971;
S strain msa-2c, DQ173972; T vaccine strain msa-2c, DQ173973; T2Bo strain
msa-2c, DQ173974; F3 msa-2 locus, DQ173975; F35 msa-2 locus, DQ173976;
F40 msa-2 locus, DQ173977; G06 msa-2 locus, DQ173978; G36 msa-2 locus,
DQ173979; G51 msa-2 locus, DQ173980; G52 msa-2 locus, DQ173981; L strain
msa-2 locus, DQ173982; S strain msa-2 locus, DQ173983; T vaccine strain msa-2
locus, DQ173984; T2Bo strain msa-2 locus, DQ173985.
RESULTS
Characterization of the msa-2 locus. The msa-2 locus of the
B. bovis biological clone Mo7 has four tandemly arranged
msa-2 genes separated by identical intergenic regions (10). To
determine whether this architecture is preserved across other
American and Australian strains and isolates, amplification of
the entire locus from T2Bo, a virulent strain from Texas, and
L, a virulent Australian strain, was performed utilizing PCR
(Fig. 1A). Products of approximately 6.3 kb were generated
from Mo7 (the positive control) and T2Bo, which correlates
well with the expected size based upon the published Mo7
sequence and the sequence of a BAC clone that contains the
T2Bo msa-2 locus. Amplification of the L strain, in contrast,
resulted in an amplicon of approximately 3.2 kb, a length which
allows for only two msa-2 genes. To confirm the apparent
reduction in msa-2 genes, long-distance PCRs were cloned,
subcloned, and sequenced. The results are shown in a sche-
matic of the loci in Fig. 1B. While T2Bo has a locus organiza-
tion similar to that of Mo7, L has only one additional msa-2
gene that lies between msa-2c and orfB. This Australian
L strain msa-2 gene is similar in length, position within the
locus, and sequence to both msa-2a and -2b from previously
characterized loci (10). Because of the evolutionary relation-
ship between this gene and both msa-2a and -2b genes of Mo7
and R1A (10), we have designated this gene msa-2a/b. For the
purposes of genetic comparisons in this study, we will refer to
the group of all msa-2a, -2b, and -2a/b sequences as msa-2a/b
genes and the predicted proteins that they encode as MSA-
2a/b proteins.
Amplifications over long distances have been reported to
generate in vitro recombinants (27). To verify that the organi-
zation of the msa-2 loci had been maintained throughout the
amplification process, Southern blots of T2Bo and L genomic
and cloned DNA digested with PstI (T2Bo) or EcoRI/HindIII
(L) and probed with msa-2a/b-specific oligonucleotides were
examined (Fig. 1C). The digestions resulted in the predicted
4,700-bp fragment from T2Bo and 2,300-bp fragment from
L genomic and cloned DNA. Based on these results, long-
distance PCR appeared to faithfully amplify the msa-2 locus
from genomic DNA.
The msa-2 loci from the Australian T vaccine strain, vaccine
breakthrough isolates of the F and G series (F3, F35, F40, G06,
G36, G51, and G52), and the virulent S strain were amplified
from genomic DNA and produced, similarly to the L strain, a
3.2-kb amplicon. All loci have an organization identical to that
of the L strain, with one msa-2c gene at the 5 end of the locus
and one additional msa-2a/b gene located 3 of msa-2c.
Analysis of MSA-2a/b protein sequences. msa-2a/b genes
were sequenced from the virulent Australian L and S strains,
the Australian K and T vaccine strains, several Australian
vaccine breakthrough isolates (F and G), and the T2Bo strain
(Table 1). These sequences along with the msa-2a/b genes
from the South American R1A vaccine strain and the Mo7 lab
strain were aligned and analyzed. The MSA-2a/b molecule can
be split into four different regions: the leader sequence (M1 to
S20), the body (A21 to X200), the HVR (P201 to X300), and
the GPI anchor signal sequence (X301 to F317) (Fig. 2). The
leader and GPI anchor signal sequences, both of which are
predicted to be absent from the surface-expressed protein, are
the only highly conserved regions of the protein, with 90% and
88% overall identity among all sequences, respectively. The
body of the molecule is less conserved but has several small
islands of complete identity. Notable is a 34-residue block
(Y151 to M184, 62% identity) that contains one of the most
hydrophilic regions of the molecule (10). The block has three
stretches of absolute conservation: YYK, VKFCND, and
SPFM, as identified in previously examined American strains
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(10). Additional short regions of relative conservation are
present in the amino half of the body and include a 16-residue
stretch (T32 to T48) with 59% identity. However, the conser-
vation of 129FNAFLNDNP137, found among all R1A and
Mo7 MSA-2a/b sequences (10), is not maintained in the Aus-
tralian strains and isolates. In contrast to the body of the
molecule, the HVR is a highly divergent region with few con-
served residues and is analyzed in depth below.
Comparison of MSA-2a/b molecules from vaccine strains to
their respective breakthrough isolates. To determine whether
the level of diversity throughout the entire MSA-2a/b molecule
is associated with vaccine breakthrough, the MSA-2a/b mole-
cules of two Australian vaccine strains, T and K, were com-
pared to four each of their respective breakthrough isolates.
Sequence alignments of these comparisons are shown in
Fig. 3A and B. The deduced amino acid sequences of all
FIG. 1. The Australian virulent B. bovis L strain contains a single msa-2a/b gene. (A) Ethidium bromide-stained agarose gel of the msa-2 locus
amplified from biological clone Mo7 (lane 2), Texas T2Bo strain (lane 3), and Australian virulent L strain (lane 4) with a 1.0-kb marker in lane 1.
(B) Schematic of the msa-2 locus from T2Bo, based on the sequence of BAC clone 1K11 (see Materials and Methods), and L, based on the
nucleotide sequence of the amplified msa-2 locus. (C) Southern blot of T2Bo genomic DNA and a T2Bo msa-2 locus clone digested with PstI and
probed with digoxigenin-labeled T2Bo msa-2a/b-specific oligonucleotide (left panel) and L strain genomic DNA and L msa-2 locus clone digested
with EcoRI/HindIII and probed with digoxigenin-labeled L msa-2a/b-specific oligonucleotide (right panel). Probe detection was by chemilumi-
nescence. Size markers are in the far left and far right lanes, and the relevant markers are designated in base pairs to the left and right of the panels.
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msa-2a/b T vaccine breakthrough isolates are different from
the encoded sequence of T-1 msa-2a/b. Breakthrough MSA-
2a/b amino acid identity to the T-1 sequence ranges from 61%
to 85% (G06 and G52) with overall pairwise identities among
all G outbreak isolates that range from 64% to 79%. Thus, the
disparity between T-1 and each outbreak isolate is no greater
than the disparity among all isolates. Polymorphisms among
the sequences span the entire mature molecule with the high-
est number of changes in the HVR, sparing the leader and the
GPI anchor signal sequences. The body of the molecule, in
contrast, has several large regions with far fewer changes sep-
arated by a few small stretches of complete conservation. The
longest of these conserved runs include an eight-residue hy-
drophilic stretch near the amino end of the molecule, 41ANY
IKFLT48, and a 10-residue stretch, 169LVKFCNDELD178,
near the carboxy end. A second T vaccine strain sequence, T-2
MSA-2a/b, was also found. The G outbreak isolates are com-
parably divergent to this vaccine sequence with the exception
of G52, which has 99% identity to T-2.
Similar to the relationship between the T vaccine break-
through isolates and the T vaccine strain, all K vaccine break-
through isolate MSA-2a/b molecules are different from the
K vaccine strain (Fig. 3B). As a group, pairwise disparity
among F breakthrough isolates ranges from 67% to 100%.
Compared to the vaccine strain, for which only one sequence
was identified, F breakthrough identities range from 59% to
71% (F28 and F35/F40). The leader and GPI anchor signal
sequences are well conserved with comparable changes
throughout the body and HVR as described for the T vaccine
breakthrough isolates. The only completely conserved se-
quence in the body of the molecule is a 10-residue stretch,
169LVKFCNDELD178, near the carboxy end.
Comparisons between vaccine strain and respective vaccine
breakthrough isolate MSA-2a/b molecules also demonstrated
defined stretches of polymorphism. Similar stretches of se-
quence can be found in other Australian and American strains.
This is exemplified in Fig. 3C, which shows a multiple sequence
alignment for T-1, G06, and Mo7. While G06 MSA-2a/b has
high identity to T-1 MSA-2a/b (84.9%), two segments of G06
(denoted in boxes in Fig. 3C) have nearly complete identity to
Mo7 MSA-2a1. Similar examples have been observed among
the Mo7 and R1A MSA-2a/b molecules. As has been previ-
ously proposed, these regions appear to be sites of genetic
exchange (10).
Analysis of the hypervariable region. Comparison between
vaccine strains and their respective breakthrough isolates in-
dicates that the HVR contains the greatest amount of diversity
in the molecule and that it varies in length. To determine the
basis for this, we examined the amino acid and nucleotide
sequences of the HVR from 22 MSA-2a/b proteins. The HVRs
of MSA-2a/b proteins are extremely hydrophilic (data not
shown) and are defined at the amino end by a completely
conserved P201 and at the carboxy end by the predicted GPI
anchor signal sequence cleavage site of SFT (Fig. 2). The
length of this region varies widely from 34 (F28 MSA-2a/b) to
84 (Mo7 MSA-2a1) amino acids.
The HVR is rich in proline residues, especially in compari-
son to the remainder of the molecule (Fig. 4A). Sixteen per-
cent of residues in the combined pool of HVR codons (443
codons total) are proline. They are irregularly spaced and have
an intervening sequence length ranging from 0 to 13 residues.
To understand why this part of the molecule is proline rich,
manual alignment of representative HVRs, including the car-
boxy region of two msa-1- and two msa-2c-encoded proteins,
was performed (Fig. 4B). These manual alignments identify
three major, semiconserved, proline-containing motifs. The
first motif of 11 residues (red sequence in Fig. 4B) has a
consensus sequence of QGTTGTQ-[PQ]-SQD and is present
at least once, in whole or in part, in all HVRs at a well-
conserved position near the amino end of the HVR. The sec-
ond motif of four residues (purple sequence in Fig. 4B) has a
consensus sequence of PAAP and follows the first motif with a
variable number of intervening amino acids. The third motif of
nine residues (green sequence in Fig. 4B) has a consensus
sequence of QPTKPAETP and is limited to the carboxy half of
the HVR. It is present in whole or truncated form in all but
one of the sequences and in all but one MSA-2a/b sequence is
FIG. 2. The MSA-2a/b proteins are diverse and have a hypervariable region in the carboxy half of the molecule. An alignment similarity plot
of all examined MSA-2a/b proteins is shown. Regions of relative high identity are indicated by an overlying bar with sequence information and
composite percent identity provided. Dashes in sequences indicate nonconserved residues. A schematic of MSA-2a/b molecular organization based
on sequence variation and known function is shown below. Protein residues noted at the junction of sequence segments are initiating residues.
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associated with a semiconserved nonrepeated segment with a
consensus sequence of GNLNG (blue sequence in Fig. 4B).
To determine the codon basis of the proline-containing mo-
tifs, representative nucleotide sequences of variable lengths
from the 5 half of the msa-2a/b HVRs were aligned. The
alignment demonstrates that nearly all nucleotide sequences in
the 5 half of the HVRs can be mapped to the consensus
sequence shown in Fig. 5A.
The architecture of the HVR was delineated by dividing the
full-length consensus sequence into three segments, labeled 1,
2, and 3. Amino acid sequence segments of the HVRs were
then replaced with the segment number to which they mapped.
The product of this transformation applied to representative
MSA-2a/b HVRs (Fig. 5B) illustrates that this region is largely
composed of a chain of degenerate repeats that varies in num-
ber and order. For example, the HVR of F3 MSA-2a/b is one
FIG. 3. Vaccine breakthrough isolate MSA-2a/b protein sequences differ from their associated vaccine strains. (A) MSA-2a/b sequence
alignment of the Australian T vaccine strain compared to the vaccine breakthrough G isolates (G52, G51, G36, and G06). (B) MSA-2a/b sequence
alignment of the Australian K vaccine strain compared to the vaccine breakthrough F isolates (F3, F28, F35, and F40). The underlined se-
quences indicate stretches of complete conservation. (C) MSA-2a/b amino-terminal region alignment of T vaccine strain T-1, vaccine breakthrough
isolate G06, and Mo7 2a1. Boxes highlight regions of high identity between G06 and Mo7 2a1. Spaces denote identity, and dashes indicate gaps.
Alignments were constructed by CLUSTALW.
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of the shortest regions, partially attributable to the presence of
only four degenerate repeat segments with the order 1, 2, 2, 3.
In contrast, Mo7 MSA-2a1 has one of the longest HVRs, which
is due to the presence of at least 10 degenerate repeat seg-
ments with the order 1, 2, 3, 2, 2, 3, 2, 1, 2, 3. The repeat region
also contains a few residues that are not clearly assigned to any
one repeat segment because of their short length.
Comparison of the MSA-2a/b HVR to other VMSA family
members. All VMSA family members share a well-conserved
GPI anchor signal sequence. In contrast, this carboxy-terminal
signal sequence is preceded by an HVR in MSA-2a/b that has
very few overall similarities to other family members. There
are several examples, however, where segments of the HVR
have high identity to a corresponding sequence in other VMSA
family members (Fig. 6).
One example is between T2Bo and Mo7 MSA-2b and the
Australian MSA-1 proteins. The middles of the HVRs of these
two proteins have a full-length repeated and degenerate first
motif (Fig. 4B) that is most closely related to a similar se-
quence in a similar position in the carboxy region of four
unique Australian MSA-1 proteins, of which F35 MSA-1 is
representative. These sequence fragments, including five resi-
dues upstream, are 92% identical. Over that same stretch of
sequence, the next closest sequence relation is to G51 MSA-
2a/b (31% identity).
A second example is the sequence similarity and motif as-
sociations of R1A MSA-2a2 to MSA-2c. The third motif of
R1A MSA-2a2, unlike all other MSA-2a/b proteins, is not
associated with the GNLNG sequence (Fig. 4B). However, this
arrangement of the third motif without the adjoining sequence
is representative of nearly all MSA-2c proteins examined (9/
10). Moreover, the sequence of R1A MSA-2a/b is identical
over this stretch to F40 MSA-2c, including the eight remaining
downstream residues of the HVR.
Lastly, the region just upstream of the GPI anchor cleavage
site of F28 MSA-2c, unlike all other MSA-2c proteins, contains
the GNLNG sequence present in the HVR of most MSA-2a/b
proteins. This region, along with seven residues downstream,
has 77% identity to Mo7 MSA-2a2 and shares four residues
upstream with the truncated third motif in T2Bo MSA-2b
FIG. 4. The HVR of MSA-2a/b contains a series of three, proline-rich, repeating motifs. (A) Amino acid alignment of all 22 MSA-2a/b proteins
examined. A period replaces all nonproline residues, a red “X” replaces all proline residues, and dashes indicate gaps in sequences. (B) Manual
amino acid alignment of 10 representative MSA-2a/b HVRs along with the 3 region upstream of the GPI anchor signal sequence of F35, F40, and
R1A MSA-1 and F40 and F28 MSA-2c. Alignments are based on both amino acid and nucleotide sequences. Motifs are highlighted by color.
Sequences of the first motif are red, sequences of the second motif are purple, sequences of the third motif are green, and the common GNLNG
sequence is blue. Residues that are not assigned to a motif are in black letters. Blank spaces indicate gaps. A black bisected underline splits the
HVR into amino and carboxy regions as labeled.
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(PPQT) (Fig. 4B). Collectively, these data suggest that genetic
exchange may have occurred among all members of the VMSA
family, including msa-2a/b, msa-2c, and msa-1 genes.
Analysis of MSA-2c. Analysis of the deduced amino acid
sequences of msa-2c from all Australian and American strains
is consistent with previous findings that these proteins are
more highly conserved than MSA-2a/b across the entire mol-
ecule (10, 28). Nearly all proteins are 265 residues, and they
collectively have 75% identity, with pairwise comparisons rang-
ing from 100 to 85% identity. In contrast to the highly poly-
morphic MSA-2a/b proteins, the vaccine breakthrough
MSA-2c proteins have 92% to 100% identity to the MSA-2c of
their respective vaccine strain. F28 MSA-2c, however, is an
exception to this group. The protein is 254 residues long as a
result of three short deleted segments, with pairwise compar-
isons ranging from 53 to 55% identity to MSA-2c of all other
strains and isolates. Interestingly, however, F28 MSA-2c also is
closely related to BabR 0.8 (50% overall identity), another
VMSA family member not present in the msa-2 locus (10),
with 73% identity to the first 180 amino acid residues. All other
MSA-2c proteins are more distantly related to BabR, with
overall identities that range between 39% and 40%.
DISCUSSION
B. bovis vaccine breakthrough isolates are genetically and
antigenically distinct from vaccine strains (12, 13). These dif-
ferences are, in part, due to the MSA-1 proteins, which in these
breakthrough isolates have recently been shown to encode
strain-specific epitopes not shared with vaccine strains (12).
FIG. 5. The amino-terminal region of the HVR is encoded by a series of degenerate nucleotide repeats. (A) Nucleotide sequence alignment
of representative segments from the amino-terminal region (Fig. 4B) of HVRs. Base pair substitutions in reference to the consensus sequence are
italicized; base pairs identical with the consensus sequence are red. The encoded amino acid sequences of these segments, with their relative
positions in the 5 region of the HVR, are aligned in the left half of the figure. The amino acid alignment is partitioned into three segments and
numbered as indicated at the top of the alignment. “Md” indicates sequences derived from the middle portion of the amino half of the HVR region.
Spaces denote gaps. (B) Sequences of the of representative HVRs with transformation of the amino acid sequence fragments of the 5 region with
the segment number to which their nucleotide sequences mapped.
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Comparison of MSA-2a/b proteins reveals that, like MSA-1,
nearly all MSA-2a/b proteins from Australian B. bovis vaccine
breakthrough isolates examined are significantly different from
the MSA-2a/b proteins of the vaccine strains used to immunize
these animals. These differences could reflect allelic preva-
lence in the field population working independently of immune
selection. In addition, the occurrence of outbreaks in vacci-
nated herds is clearly a multifactorial event that may not always
correlate with laboratory challenge (5). However, the observa-
tions that these genes encode exceptionally polymorphic, sur-
face-expressed proteins and that monospecific sera directed
toward them can block erythrocyte invasion (16) are all con-
sistent with immunologic selection for change within the
breakthrough isolate MSA-2a/b proteins. Many of the changes
between the vaccine strain and the breakthrough isolates are in
hydrophilic regions of the body and in the repeat region within
the HVR, both of which are predicted to be highly antigenic
(data not shown).
The only region of the predicted mature molecule that is
semiconserved among vaccine strains and their breakthrough
isolates, as well as in MSA-2a/b proteins of all other strains, is
in the central region of the molecule containing the YYK
motif. A similar motif (YFK), also in the central region of the
molecule, is completely conserved in the MSA-1 proteins ex-
amined from Australia and America (12), suggesting that this
part of the molecule in both MSA-1 and MSA-2a/b may have
the same function. The tripeptide along with two semicon-
served downstream residues, YYK-[KN]-[EH], is reminiscent
of the binding motif (YY-[LIV]-[DN]-H) contained within
WW modules, well-described motifs that bind proline-rich and
phosphorylated targets (14). The regions containing these two
motifs, intriguingly, are predicted to have similar secondary
structures (data not shown).
The HVR is one of the most hydrophilic regions of the
molecule and, interestingly, is proline rich as a result of three,
frequently repeated, proline-containing, semiconserved motifs.
HVR-specific monoclonal antibodies (11) bind to the surface
of live merozoites (20), and monospecific antiserum directed
against MSA-2a/b proteins blocks erythrocyte attachment and
invasion (16). Taken together, these findings imply that the
HVR may be involved with the initial interactions between
merozoites and the erythrocyte surface during invasion. Sev-
eral well-described Plasmodium surface proteins involved in
cell invasion and the procyclins of Trypanosoma brucei also
contain proline-rich regions (PRRs). Plasmodium vivax and
Plasmodium knowlesi Duffy receptor proteins have central
PRRs (9) that have recently been shown to contain the ele-
ments responsible for binding Duffy antigens (25), allowing
invasion only in Duffy antigen-positive individuals. Duffy blood
group antigens have also been described for cattle, and the
ability of B. bovis to infect erythrocytes from different species
of cattle positively correlates with the prevalence of Duffy
antigen expression in different species (18). The central repeat
region II of the circumsporozoite protein (CSP) of several
Plasmodium spp. also constitutes a PRR (7, 22) that appears to
function as a linker between two binding domains implicated in
hepatocellular adhesion. The procyclins of T. brucei are GPI-
anchored surface proteins expressed during the life cycle in the
tsetse fly that, similar to the MSA-2a/b proteins, have PRRs
abutting the GPI anchor signal sequence (29). Acosta-Serrano
et al. postulate that the function of this region could be to
protect the parasite during its passage through the midgut (1).
How and when MSA-2a/b proteins undergo variation are not
clear. The amino acid changes within the body of the molecule
range from numerous scattered substitutions and rare short de-
letions to large segments of sequence diversity that are shared in
other MSA-2a/b proteins suggestive of genetic exchange. The
most variable part of the molecule, though, is the HVR; it has no
regions of complete conservation and contains large indels. Much
of this length variation can be attributed to the presence of a
series of variable numbers of degenerate repeats in the 5 end of
the HVR. This is reminiscent of the central region II of the
Plasmodium CSP, which is composed of 25 to 40 short proline-
containing, tandemly arranged, repeating motifs (3). Slipped-
strand mispairing, occurring during clonal expansion, has been
implicated in generating the differences in the number of repeats
between different clones of Plasmodium falciparum and Plasmo-
dium reichenowi (21). The types of changes generated by this
method have yet to be observed in the B. bovis VMSAs. As these
HVR polymorphisms likely lead to changes in surface epitopes, a
clearly useful application of this method of diversification, as well
as gene conversion, would be during clonal expansion within the
mammalian host. Finely targeted unequal crossover events within
the HVR can also lead to a series of repeats in this region. As the
sexual stages of B. bovis occur in Boophilus microplus, variation in
the HVR produced by this method would occur during passage of
the parasite through the tick vector. Studies designed to deter-
mine in what part of the life cycle and how these changes arise, as
well as how these changes may affect escape from immune rec-
ognition, are currently under way.
Initial characterization of the msa-2 locus in the biological
clone Mo7 demonstrated that the locus contained three msa-
2a/b genes (-2a1, -2a2, and -2b) and one msa-2c gene (10).
While another American strain, T2Bo, similarly has four msa-2
genes in the locus, the msa-2 locus from 12 Australian strains
and isolates has only one msa-2a/b and one msa-2c gene. How
the presence of only a solitary msa-2a/b gene in the Australian
loci affects the generation of sequence diversity, compared to
multigene loci such as Mo7 and T2Bo, is unknown. Several
mechanisms of gene diversification, such as gene conversion
FIG. 6. The HVR has sequence similarities to other VMSA family
members. Three separate amino acid alignments are shown. Sequences
shared among VMSA family members are boldfaced. The bracketed
segments highlight motifs 1 and 3 as specified in the text (Fig. 4).
Dashes indicate sequence gaps. The fractions listed at the right of the
sequences are the frequency with which the representative sequence
segments are present in the indicated VMSA family members that
were examined.
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and homologous recombination, depend a priori on pools of
similar genetic material. Because the Australian msa-2 loci
have only one msa-2a/b gene, the pool of genetic material
available for these mechanisms is limited in comparison to
multigene loci. Nevertheless, the ability of these isolates to
persist in the mammalian host and in the population, coupled
with their postulated role in host immune system evasion,
indicates that mechanisms of generating diversity in these loci
provide sufficient variability. While this could be accomplished
by homologous recombination or gene conversion among msa-
2a/b genes from different isolates, occurring in the tick vector
and/or mammalian host, sequence similarities among MSA-
2a/b, MSA-2c, and MSA-1 suggest that additional sources of
genetic material available for genetic exchange may include
msa-1 and msa-2c.
In summary, the msa-2 locus of all Australian B. bovis strains
and isolates examined, unlike the American strains, contains
only two msa-2 genes: one msa-2c and one msa-2a/b gene.
Analysis of 22 msa-2a/b genes from 16 different American and
Australian B. bovis strains and isolates indicates that these
genes encode a diverse set of proteins. As hypothesized, the
encoded MSA-2 proteins of Australian vaccine breakthrough
strains are different from the MSA-2 proteins of their vaccine
counterpart, suggesting that these proteins may be involved in
strain-specific protective immunity. The greatest diversity
among MSA-2a/b proteins is in a hypervariable region, up-
stream of the GPI anchor signal sequence, which arises from
variable numbers of proline-rich, degenerate repeats, similar
to the repeat regions of Plasmodium CSP and T. brucei procy-
clins. Whether changes in the HVR arise only during the sex-
ual stages, occurring in the tick vector, or also during passage
through the mammalian host is under investigation.
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